Frank McEnulty, President, CEO at Cell MedX Corp. (CMXC), bought 481,016 shares at $0.25 ($120K) on 2017-10-12, disclosed to the SEC on 2017-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.